샘플 요청 목록

 카트 문의
시장보고서
상품코드
1533902

세계의 신생아 청각 스크리닝 장치 시장

Neonatal Hearing Screening Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 274 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

신생아 청각 스크리닝의 세계 시장은 2030년까지 4,940만 달러에 달할 전망

2023년에 3,960만 달러로 추정되는 신생아 청각 스크리닝 장치 세계 시장은 2030년에는 4,940만 달러에 이르고, 분석 기간 2023-2030년의 CAGR은 3.2%로 성장할 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 청성뇌간반응(ABR) 시스템은 CAGR 3.3%로 성장을 지속하고, 분석 기간 종료까지 2,250만 달러에 달할 것으로 예측됩니다. Otoacoustic Emission(OAE) 시스템 분야의 성장률은 분석 기간 동안 CAGR 3.8%로 추정됩니다.

미국 시장은 1,080만 달러, 중국은 CAGR 6.2%로 성장 예측

미국 신생아 청각 스크리닝 시장은 2023년 1,080만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2023년부터 2030년의 분석 기간에 CAGR 6.2%로 추이했으며, 2030년에는 예측시장 규모 1,010만 달러에 달할 것으로 예측되고 있습니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.0%와 2.4%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 1.7%로 성장할 것으로 예측됩니다.

세계 신생아 청각 스크리닝 장비 시장 - 주요 동향 및 촉진요인 요약

신생아 청각 스크리닝은 어린이의 언어 능력, 사회성 발달에 큰 영향을 미치는 청력 상실을 확인하는 중요한 조기 개입 수단으로 인식됩니다. 신생아 청각 스크리닝(UNHS)은 청각 장애를 조기에 발견함으로써 그 영향을 크게 줄일 수 있기 때문에 세계 병원에서 도입이 진행되고 있습니다. 신생아 청각 스크리닝은 생후 곧 실시되며, 일련의 비침습적이고 통증이 없는 검사를 통해 아기의 청각 건강 상태를 신속하게 결정할 수 있습니다. 아기의 언어 발달 능력은 생후 1년 만에 가속적으로 향상되므로 미래의 커뮤니케이션과 교육 문제를 예방하기 위해서는 조기 발견과 개입이 필수적입니다.

기술의 진보로 신생아 청각 스크리닝의 효과와 사용 편의성이 크게 향상되었습니다. 최신 기기에서는 음향 방사선(OAE)과 청성 뇌간 반응(ABR) 검사가 통합되어 CE-Chirp와 같은 향상된 자극으로 보다 빠르고 정확한 종합적인 청각 평가 가능합니다. 이 통합은 스크리닝 프로세스를 단순화하고 여러 장비의 필요성을 줄이고 전체 검사 시간을 단축합니다. 또한 이러한 장비의 진화로 인해 사용하기 쉽고 데이터베이스에 연결할 수 있어 환자 기록을 체계적으로 관리하고 분석할 수 있어 후속 케어와 청각 건강에 관한 종단적 연구 쉬워졌습니다.

신생아 청각 스크리닝 시장의 성장은 충분한 서비스를 받지 못한 지역으로 도달범위를 확대하는 원격 의료 서비스와 장비의 통합과 같은 기술적 진보를 포함한 여러 요인들에 의해 견인되고 있습니다. 또한, 센서 기술의 강화는 스크리닝의 정확성과 신뢰성을 향상시키고 그 채택을 증가시키고 있습니다. 휴대용으로 사용하기 쉬운 디자인의 기기는 병원뿐만 아니라 커뮤니티 센터나 가정에서의 사용도 촉진해 조기 발견의 범위를 넓히고 있습니다. 또한, 교육 캠페인과 규제 당국의 지원에 뒷받침되는 소비자의 의식 향상이 보다 넓고 일상적인 사용을 촉진하고 있습니다. 장비 제조업체와 의료 전문가의 협력으로 장비 개선이 계속되고 임상 환경에 대한 적응성과 효과가 높아지고 있습니다. 이러한 스크리닝 프로토콜을 채택한 병원에 대한 경제적 인센티브는 보다 광범위한 도입을 보장하고 이 필수적인 의료 기술의 전반적인 성장과 발전에 기여하고 있습니다.

조사 대상 기업 예(전 37건)

  • Draeger India Private Limited
  • Echodia SAS
  • Grason-Stadler, Inc.
  • Guangzhou Melison Medical Instrument Co., Ltd.
  • iClear Healthcare
  • Intelligent Hearing Systems Corp.
  • Interacoustics A/S
  • MAICO Diagnostics GmbH
  • Natus Medical Incorporated
  • Neurosoft
  • Otodynamics Ltd
  • Path Medical GmbH
  • Pilot Blankenfelde medizinisch elektronische Gerate GmbH
  • Sohum Innovation Lab
  • Vivosonic Inc.;

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

JHS 24.08.23

Global Neonatal Hearing Screening Devices Market to Reach US$49.4 Million by 2030

The global market for Neonatal Hearing Screening Devices estimated at US$39.6 Million in the year 2023, is expected to reach US$49.4 Million by 2030, growing at a CAGR of 3.2% over the analysis period 2023-2030. Auditory Brainstem Response (ABR) Systems, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$22.5 Million by the end of the analysis period. Growth in the Otoacoustic Emission (OAE) Systems segment is estimated at 3.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$10.8 Million While China is Forecast to Grow at 6.2% CAGR

The Neonatal Hearing Screening Devices market in the U.S. is estimated at US$10.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$10.1 Million by the year 2030 trailing a CAGR of 6.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.0% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

Global Neonatal Hearing Screening Devices Market - Key Trends and Drivers Summarized

Neonatal hearing screening is recognized as a crucial early intervention measure to identify hearing loss, which can profoundly impact a child's development of speech, language, and social skills. Hospitals around the world are increasingly incorporating Universal Newborn Hearing Screening (UNHS) programs, motivated by the potential to significantly mitigate the effects of auditory impairments recognized early in life. The process, conducted shortly after birth, involves a series of non-invasive, painless tests that can quickly determine a baby's auditory health status. This proactive approach is crucial because a baby’s capacity for speech and language development accelerates within the first year of life, making early detection and intervention essential for preventing future communicative and educational challenges.

Technology advancements have greatly enhanced the efficacy and accessibility of newborn hearing screenings. Modern devices integrate both Otoacoustic Emissions (OAE) and Auditory Brainstem Response (ABR) tests, allowing for comprehensive auditory assessments that are both faster and more accurate, thanks to improved stimuli like CE-Chirp. This integration simplifies the screening process, reduces the need for multiple devices, and accelerates the overall testing time—factors that increase efficiency in a clinical setting. Moreover, the evolution of these devices has made them more user-friendly and capable of connecting to databases, which helps in maintaining and analyzing patient records systematically, facilitating follow-up care and longitudinal studies on auditory health.

The growth in the neonatal hearing screening market is driven by several factors including technological advancements, such as the integration of devices with telehealth services, which expand reach to underserved areas. Additionally, enhancements in sensor technology improve the accuracy and reliability of screenings, increasing their adoption. Portable and user-friendly designs of the devices promote their use not only in hospitals but also in community centers and at home, broadening the scope of early detection. Furthermore, increased consumer awareness, backed by educational campaigns and regulatory support, encourages more widespread and routine use. Collaboration between device manufacturers and healthcare professionals continues to refine the devices, making them more adaptable and effective in clinical environments. Economic incentives for hospitals to adopt these screening protocols ensure a broader implementation, contributing to the overall growth and development of this essential healthcare technology.

Select Competitors (Total 37 Featured) -

  • Draeger India Private Limited
  • Echodia S.A.S
  • Grason-Stadler, Inc.
  • Guangzhou Melison Medical Instrument Co., Ltd.
  • iClear Healthcare
  • Intelligent Hearing Systems Corp.
  • Interacoustics A/S
  • MAICO Diagnostics GmbH
  • Natus Medical Incorporated
  • Neurosoft
  • Otodynamics Ltd
  • Path Medical GmbH
  • Pilot Blankenfelde medizinisch elektronische Gerate GmbH
  • Sohum Innovation Lab
  • Vivosonic Inc.;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Neonatal Hearing Screening Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Need to Identify Congenital Deafness & Hearing Impairment in Newborns Drives Demand
    • Technological Advancements in Screening Devices Enhance Detection Accuracy
    • Smartphone-Based Hearing Test for Infants Ignites Interest in the Market
    • Growing Healthcare Expenditure in Emerging Markets Bolsters Device Adoption
    • Development of Low-cost Earbuds Makes Newborn Hearing Screening Accessible
    • Telemedicine for Audiology Screening of Infants Rises in Popularity
    • Economic Burden of Undiagnosed Hearing Loss Supports Case for Early Screening
    • Adoption of Newborn Hearing Screening in Private Healthcare Sectors
    • Growing Number of Births in Medical Facilities Increases Market Coverage
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neonatal Hearing Screening Devices Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neonatal Hearing Screening Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Neonatal Hearing Screening Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Auditory Brainstem Response (ABR) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Auditory Brainstem Response (ABR) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Auditory Brainstem Response (ABR) Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Otoacoustic Emission (OAE) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Otoacoustic Emission (OAE) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Otoacoustic Emission (OAE) Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Combination Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Combination Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Combination Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Neonatal Hearing Screening Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Neonatal Hearing Screening Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Neonatal Hearing Screening Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Neonatal Hearing Screening Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Neonatal Hearing Screening Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Neonatal Hearing Screening Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Neonatal Hearing Screening Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Neonatal Hearing Screening Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제